Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

During the first peak of the coronavirus pandemic, it became apparent that the processing of the standard COVID-19 test using nasal swab samples, while considered a gold standard, was slow, taking over 24 hours to give results in most cases.

As demand for quicker test results increased with supplies running low, scientists and engineers rushed to fill the gap at scale for rapid diagnostic testing that would replace the standard real-time reverse transcription polymerase chain reaction (rt-PCR) test.

Such technologies included rapid antigen tests, antibody tests, as well as tests using the loop-mediated isothermal amplification method (LAMP) and mass spectrometry. The UK is currently deploying “lateral flow” antigen tests, which deliver results on the spot, are cheap and easily mass produced. However they have important limitations.

With so many different types of test now on the market, how do we sort the wheat from the chaff and work out what form of testing is best for which healthcare or community setting? Our research group is testing the tests to find out.

Read the full article on The Conversation website, co-written by Gail Hayward, Nuffield Department of Primary Care Health Sciences website.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.